Frequency, Risk Factors, and Pregnancy Outcomes in Cases with Placenta Accreta Spectrum Disorder: A Case-Control

Mitra Tadayon1, Nahid Javadifar1, Maryam Dastoorpoor2

  • 1Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Insights

Placenta accreta spectrum (PAS) is a life-threatening condition. Key risk factors include prior cesarean delivery and placenta previa, leading to significant maternal morbidity like hysterectomy and preterm birth.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Placenta accreta spectrum (PAS) disorder represents a significant life-threatening obstetric complication.
  • Understanding the epidemiology and risk factors of PAS is crucial for improving maternal outcomes.

Purpose of the Study:

  • To determine the frequency of PAS in a tertiary referral university hospital in Ahvaz, Iran.
  • To identify independent risk factors associated with PAS development.
  • To evaluate the pregnancy outcomes and maternal morbidity in women with PAS.

Main Methods:

  • A case-control study was conducted from 2015 to 2019, including 187 PAS cases and 552 controls.
  • Multivariable logistic regression analysis identified independent risk factors for PAS.
  • Pregnancy outcomes were assessed using statistical tests (chi-square, t-test, Mann-Whitney U) with significance set at p<0.05.

Main Results:

  • The frequency of PAS was 3.7 per 1000 deliveries (0.37%).
  • Independent risk factors identified include prior cesarean delivery (OR=52.55), placenta previa (OR=27.48), multigravidity (OR=2.98), and multiparity (OR=2.05).
  • PAS was associated with high rates of hysterectomy (60.4%), blood transfusion (73.7%), ICU admission (42.8%), preterm birth (61.4%), and perinatal mortality (7.4%).

Conclusions:

  • The incidence of PAS in this Iranian population is comparable to global figures.
  • Prior cesarean delivery, placenta previa, multigravidity, and multiparity are significant risk factors for PAS.
  • Perinatal hysterectomy and preterm birth remain the most critical complications associated with PAS.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
450
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
28